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1 Glossary of Terms: Vision Screening 
Abnormal test result ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ  ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƌĂů
ƚŽĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x Tested and ƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƚŽ
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
1%. 
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False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
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Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2 Abbreviations 
ACT  Alternating Cover Test 
AR  Autorefraction 
AS  Automated Screening 
CT  Cover Test 
CV  Colour Vision 
EI Eye Inspection 
EM  Eye Motility 
Fix  Fixation 
GDP  Gross Domestic Product 
GP General Practitioner 
Hir  Hirschberg test 
NICU Neonatal-intensive care unit 
PM Pursuit Movements 
PPP  Purchasing Power Parity 
PR  Pupillary Reflexes 
RE  Retinal Examination 
ROP Retinopathy of Prematurity 
RR  Red Reflex Testing 
SV  Stereopsis 
VA  Visual Acuity  
WHO  World Health Organisation 
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3 Population and Healthcare Overview 
The population of Iceland is 341,284 (World Bank, 2018a) and a birth rate estimated at 12 
births/1,000 population in 2016 (World Bank, 2018b). The change in population and birth 
rate from 1960 to 2017 is shown in Figure 1, graphs A and B respectively. 
Iceland has an estimated population density of 3.4 people per square kilometre in 2017 and 
this has increased from 1.8 people per square kilometre in 1961 (World Bank, 2018c). In 
terms of healthcare facilities, the total density of hospitals in 2013 was 3.64 per 100,000 
population (WHO, 2016a). Infant mortality in 2017 is estimated at 1.6 deaths/1,000 live 
births in total (World Bank, 2018d). 
The average life expectancy in Iceland is estimated at 82.5 years (World Bank, 2018e), with 
a death rate of 6.9 deaths/1,000 population in 2016 (World Bank, 2018f). Iceland has a gross 
national income per capita (PPP int. $, 2013) of $38,000 (WHO, 2016b). The estimated total 
expenditure on health per capita in 2014 was $3,882 (Intl $) and the total expenditure on 
health in 2014 as percentage of GDP was 8.9% (WHO, 2016b). 
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Figure 1: Change in the Total Population and Birth Rate in Iceland between 1960 and 2017 
 
Source: Information sourced from World Bank (2018) 
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4 Vision Screening Commissioning and Guidance 
In Iceland, there are national guidelines for conducting vision screening.  Vision screening is 
funded by the state and is embedded into a general preventative child healthcare screening 
system. The content of the vision screening programme is decided upon by ophthalmologists 
and the Public Health Organisation. The vision screening programme began in 1974. Between 
the years of 1999 and 2009, visual acuity was tested at 3.5 years and 5 years by nurses in 
primary healthcare centres, but since 2009 visual acuity testing has commenced in children 
at 4 years old; instead of at 3.5 years and again at 5 years of age. Vision screening is organised 
nationally, with no regional variation between protocols. 
The procedures for vision screening can be found in the national general health screening 
guidelines. The Directorate of Health regularly updates the guidelines for general screening 
in children, including vision screening.  Updates were completed in 1996, 2009, 2010, 2013 
and the last update was in 2016. Regarding the vision screening, recommendations are made 
by ophthalmologists. The programme has not changed since 2009. There are no methods for 
quality monitoring of vision screening imposed by the government.  
Vision screening is performed by paediatricians, general practitioners (GP) and nurses. It is 
not known how many vision screening professionals there are per million people. No general 
professionals have been identified that do not screen, but could do so with additional training. 
There are specific guidelines in place for nurses, paediatricians and GPs to follow concerning 
vision screening. It is not known if there is any specific training to perform vision screening.  
There has been no cost-effectiveness analysis of the vision screening programme and there 
have been no other studies on the effectiveness of the vision screening programme in Iceland.  
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5 Screening programme  
The target conditions screened for by vision screening are retinopathy of prematurity (ROP), 
congenital cataract, amblyopia, reduced visual acuity, refractive error, colour vision defects, 
and strabismus. The health care professionals delivering vision screening, venue for screening 
and tests used vary depending on the age of the child as shown in Tables 1, 2 and 3 
respectively. Specific details of the screening offered within each age group are described 
more fully in sections 5.1 to 5.4 below. 
5.1 Vision screening - Preterm babies 
Preterm babies up to the age of 3 months are screened by an ophthalmologist in a hospital. 
The vision screening tests conducted are designed to detect retinopathy of prematurity (ROP). 
There are no guidelines concerning the number of repeated screens before referral, this is at 
the discretion of the screener. 
5.2 Vision screening - Birth to 3 months 
Well, healthy babies aged up to 3 months are screened by either a nurse, paediatrician or a 
GP in a primary healthcare centre. The vision screening tests conducted include eye 
inspection, fixation, red reflex testing, cover test, alternating cover test and eye motility. It is 
only the paediatrician who performs fundus red reflex examination to diagnose a white pupil, 
the rest of the tests are performed by both paediatrician or a nurse. The sequence of eye 
screening tests are:  
x 5 days old: Paediatrician  ? eye inspection, red reflex testing 
x 6 weeks old: Nurse and pediatrician or GP - eye inspection, red reflex test, fixation, 
cover test, alternating cover test and eye motility  
x 9 weeks old: Nurse - eye inspection, red reflex test, fixation, cover test, alternating 
cover test and eye motility 
There are no defined guidelines on how many abnormal and how many inconclusive tests 
necessitate referral for further diagnostic examination.  
5.3 Vision screening - 3 months to 36 months 
Children aged 3 to 36 months are screened by either a paediatrician, GP, or a nurse in primary 
health care centre.  
The tests conducted include eye inspection, fixation, red reflex testing, cover test, alternating 
cover test and eye motility; this is recommended at every visit. The sequence of vision 
screening are: 
x 3 months old: Nurse and pediatrician or GP.  
x 5 months old: Nurse 
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x 6 months old: Nurse 
x 8 months old: Nurse 
x 10 months old: Nurse and pediatrician or GP 
x 12 months old: Nurse 
x 18 months old: Nurse and pediatrician or GP 
x 2.5 years old: Nurse 
5.4 Vision screening - 36 months to 7 years 
Children aged 36 months to 7 years are screened by a nurse in a primary healthcare centre or 
schools. The tests conducted include eye inspection, fixation, eye motility, cover test, 
alternating cover test, visual acuity measurement and stereopsis (Titmus or Lang). The visual 
acuity measurement and stereopsis are both conducted from 4 years of age. The same 
optotype charts are used and all visual acuity measurements are conducted by nurses. 
 
The optotype charts used for visual acuity measurement include Lea symbols (logMAR) and 
HOTV (Crowded linear test): referral criteria are visual acuity of less than 0.8 decimal (0.3 
logMAR, 6/12 Snellen). Visual acuity is measured again at school age (6 years) with referral 
criteria of less than 1.0 decimal (0.00 logMAR, 6/6 Snellen), and again at 9, 12 and 14 years of 
age (referral criteria of less than 1.0 decimal (0.00 logMAR, 6/6 Snellen).  
 
Referral for further diagnostic examination is necessitated after one abnormal test result. It 
is not known how many inconclusive test results determine the need for referral for further 
diagnostic examination.
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Table 1: Healthcare professionals who conduct vision screening in each age group. 
Table 1 Paediatrician Nurse Ophthalmologist GP 
Preterm babies  × × 9 × 
0 to 3 months  9 9 × 9 
3 to 36 months  9 9 × 9 
3 to 7 years  × 9 × × 
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Table 2: Vision screening tests used in vision screening for each age group. 
Table 2 ROP EI Fix RR EM CT ACT VA SV 
Preterm babies  9 × × × × × × × × 
0 to 3 months  × 9 9 9 9 9 9 × × 
3 to 36 months  × 9 9 9 9 9 9 × × 
3 to 7 years  × 9 9 × 9 9 9 9 9 
 
Key: ROP: Retinopathy of prematurity; EI: Eye inspection; Fix: Fixation; RR: Red reflex testing; EM: Eye motility; CT: Cover test; ACT: Alternating 
cover test; VA: Visual acuity measurement; Stereopsis  
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Table 3: Location of vision screening for each age group. 
 
Table 1 
Primary Healthcare Centre Hospital School 
Preterm babies  × 9 × 
0 to 3 months  9 × × 
3 to 36 months  9 × × 
3 to 7 years  9 × 9 
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6 Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error in infants from 6 months of age. It provides objective results and 
is used to detect amblyopic risk factors. This differs from other methods used to screen 
children for amblyopia which focus on detection of the actual condition and the resulting 
visual loss. No automated screening devices are used in primary healthcare centres in Iceland.  
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7 Provision for Visually Impaired  
There are no special schools for blind or severely visually impaired children in Iceland, all 
children attend regular mainstream primary school and get support from The National 
Institute for the Blind, Visually Impaired and Deafblind. Support is provided in the form of 
refunds for glasses, optical aids technology and special reading material. The costs per child 
for these additional services are unknown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
  
Summary Vision Screening Data: Iceland                                                                             
                  
11 
 
8 Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
The prevalence of treated or untreated amblyopia by the age of 7 years is unknown, there are 
no published studies on this issue. The prevalence of persistent amblyopia (missed by 
screening or failed treatment) by the age of years is also unknown. The prevalence of 
strabismus is unknown, there has been no study investigating this. There is no data available 
concerning the incidence of the four types of amblyopia (strabismic, refractive, combined 
mechanism and deprivation), per age, per year in Iceland.  
8.2 Coverage 
It is estimated that between 90% and 100% of children are invited for vision screening in 
Iceland; administrative personnel send invitations. The coverage of vision screening, before 
the age of 7 years, is estimated at 95%. The coverage of visual acuity measurements as part 
of vision screening, before the age of 7 years, is estimated that 95% and of those 95% attend 
this appointment.  
8.3 Screening evaluation 
The percentage of false negatives for vision screening is estimated at less than 10%. The 
percentage of false positives is estimated at 10%.. The positive predictive value (PPV) of a 
refer result is not known. The sensitivity and specificity of vision screening is unknown 
8.4 Treatment success  
There is no data concerning the percentage of infants treated for strabismus or amblyopia. It 
is estimated that there have been 17 children diagnosed and treated for congenital cataract 
since 2001. Ophthalmologists are the only professionals who prescribe glasses for children 
under the age of 7 years. Other treatment options include patching, strabismus surgery and 
cataract surgery. All children that fail vision screening are referred to an ophthalmologist for 
treatment. Iceland have the capacity to treat all children and the costs are covered by the 
state, very few children are not treated. 
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9 Costs of vision screening in children 
9.1 Cost of vision screening  
The salary costs per year for vision screening professionals is not provided. The cost to train 
general preventative child healthcare screening professionals that have been specified, 
between leaving secondary education to qualification, is not provided. The total screening 
costs, per year, for vision screening and the total costs, per child per year, for vision screening 
is not provided. 
9.2 Cost of treatment for amblyopia 
The estimated costs for treatment of typical patients, with refractive amblyopia and 
strabismic amblyopia including follow up is unknown. 
9.3 Cost of Treatment for strabismus  
 The estimated costs for strabismus surgery including follow up is unknown. 
9.4 Cost of treatment for cataract 
The estimated costs for congenital cataract surgery, glasses, patching and follow-up of 
deprivation amblyopia are not available. 
Vision screening is free of charge for parents, there is no financial reward when children do 
attend and no penalty when they do not. 
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